Why These 2 Biotech Stocks Could Be Must-Owns This May

After a massive rally last year, biotech stocks have underperformed since February of this year. The author of today’s article, however, believes that the selloff in biotech is overdone – and that it offers investors an opportunity to pick up two stellar biotech firms at discounted prices. For the two biotech stocks in question, CLICK HERE.